Clinical effect of three-position points combination acupuncture in the treatment of chronic central serous chorioretinopathy
Objective To observe the clinical effect of three-position points combination acupuncture in the treatment of chronic central serous chorioretinopathy(CSC).Methods A total of 84 patients with chronic CSC treated in Shanghai First People's Hospital from January to December 2022 were divided into control group(42 cases)and treatment group(42 cases)according to random number table method.The control group was given basic treatment with Vitamin B 1 Tablets,Inosine Tablets,and Adenosine Disodium Triphosphate Tablets(40 d).Based on the control group,the treatment group was combined with three-position points combination acupuncture therapy,once every other day,a total of 20 times(40 d).The clinical effects of the two groups were compared,and the changes of the National Eye Institute visual function questionnaire-25(NEI-VFQ-25),traditional Chinese medicine symptom and syndrome scale,and best corrected visual acuity(BCVA)before and after treatment were compared between the two groups.Results Three cases dropped out of the control group and four cases dropped of the treatment group.The clinical effect of the treatment group was better than that of the control group,and the difference was statistically significant(P＜0.05).After treatment,NEI-VFQ-25 score and BCVA in two groups were higher than those before treatment,and those in treatment group were higher than those in control group,the differences were statistically significant(P＜0.05).After treatment,the score of traditional Chinese medicine symptom and syndrome scale in the treatment group was lower than that before treatment and control group,and the differences were statistically significant(P＜0.05).Conclusion The effect of three-position points combination acupuncture combined with basic treatment of chronic CSC is remarkable,and it has high clinical promotion and application value.
Three-position points combinationAcupunctureChronic central serous chorioretinopathyClinical study
万方数据
维普
